TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs6801985
log Bayes Factor = 27.947
Chromosome 3   position 38,005,183  (GRCh37) Explore rs6801985 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
L72.1 Trichilemmal cyst
1.000 0.000 0.000
L72 Follicular cysts of skin and subcutaneous tissue
0.684 0.316 0.000
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified
0.587 0.413 0.000
L72.8 Other follicular cysts of skin and subcutaneous tissue
0.500 0.500 0.000
L72.2 Steatocystoma multiplex
0.491 0.509 0.000
L72.0 Epidermal cyst
0.478 0.522 0.000
L60-L75 Disorders of skin appendages
0.243 0.757 0.000
I34.0 Mitral (valve) insufficiency
0.242 0.758 0.000
I34 Nonrheumatic mitral valve disorders
0.216 0.784 0.000
I34.1 Mitral (valve) prolapse
0.213 0.787 0.000
L73 Other follicular disorders
0.207 0.793 0.000
L65 Other nonscarring hair loss
0.195 0.805 0.000
L73.2 Hidradenitis suppurativa
0.190 0.810 0.000
L66 Cicatricial alopecia [scarring hair loss]
0.181 0.819 0.000
L75 Apocrine sweat disorders
0.174 0.825 0.000
L74 Eccrine sweat disorders
0.174 0.825 0.000
L68 Hypertrichosis
0.174 0.825 0.000
L67 Hair colour and hair shaft abnormalities
0.174 0.825 0.000
L64 Androgenic alopecia
0.174 0.825 0.000
L63 Alopecia areata
0.174 0.825 0.000
L62 Nail disorders in diseases classified elsewhere
0.174 0.825 0.000
L70 Acne
0.169 0.831 0.000
L73.8 Other specified follicular disorders
0.168 0.832 0.000
I34.8 Other nonrheumatic mitral valve disorders
0.164 0.836 0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified
0.161 0.839 0.000
L65.9 Nonscarring hair loss, unspecified
0.160 0.840 0.000
L73.1 Pseudofolliculitis barbae
0.149 0.851 0.000
L73.0 Acne keloid
0.149 0.851 0.000
L65.8 Other specified nonscarring hair loss
0.140 0.860 0.000
L65.2 Alopecia mucinosa
0.140 0.860 0.000
L65.1 Anagen effluvium
0.140 0.860 0.000
L65.0 Telogen effluvium
0.140 0.860 0.000
L66.9 Cicatricial alopecia, unspecified
0.136 0.864 0.000
L66.8 Other cicatricial alopecia
0.130 0.870 0.000
L66.4 Folliculitis ulerythematosa reticulata
0.130 0.870 0.000
L66.3 Perifolliculitis capitis abscedens
0.130 0.870 0.000
L66.2 Folliculitis decalvans
0.130 0.870 0.000
L66.1 Lichen planopilaris
0.130 0.870 0.000
L66.0 Pseudopelade
0.130 0.870 0.000
I34.2 Nonrheumatic mitral (valve) stenosis
0.129 0.871 0.000
L71 Rosacea
0.127 0.873 0.000
L62.8 Nail disorders in other diseases classified elsewhere
0.125 0.875 0.000
L62.0 Clubbed nail pachydermoperiostosis
0.125 0.875 0.000
L63.9 Alopecia areata, unspecified
0.125 0.875 0.000
L63.8 Other alopecia areata
0.125 0.875 0.000
L63.2 Ophiasis
0.125 0.875 0.000
L63.1 Alopecia universalis
0.125 0.875 0.000
L63.0 Alopecia (capitis) totalis
0.125 0.875 0.000
L64.9 Androgenic alopecia, unspecified
0.125 0.875 0.000
L64.8 Other androgenic alopecia
0.125 0.875 0.000
L64.0 Drug-induced androgenic alopecia
0.125 0.875 0.000
L67.9 Hair colour and hair shaft abnormality, unspecified
0.125 0.875 0.000
L67.8 Other hair colour and hair shaft abnormalities
0.125 0.875 0.000
L67.1 Variations in hair colour
0.125 0.875 0.000
L67.0 Trichorrhexis nodosa
0.125 0.875 0.000
L68.9 Hypertrichosis, unspecified
0.125 0.875 0.000
L68.8 Other hypertrichosis
0.125 0.875 0.000
L68.3 Polytrichia
0.125 0.875 0.000
L68.2 Localised hypertrichosis
0.125 0.875 0.000
L68.1 Acquired hypertrichosis lanuginosa
0.125 0.875 0.000
L68.0 Hirsutism
0.125 0.875 0.000
L74.9 Eccrine sweat disorder, unspecified
0.125 0.875 0.000
L74.8 Other eccrine sweat disorders
0.125 0.875 0.000
L74.4 Anhidrosis
0.125 0.875 0.000
L74.3 Miliaria, unspecified
0.125 0.875 0.000
L74.2 Miliaria profunda
0.125 0.875 0.000
L74.1 Miliaria crystallina
0.125 0.875 0.000
L74.0 Miliaria rubra
0.125 0.875 0.000
L75.9 Apocrine sweat disorder, unspecified
0.125 0.875 0.000
L75.8 Other apocrine sweat disorders
0.125 0.875 0.000
L75.2 Apocrine miliaria
0.125 0.875 0.000
L75.1 Chromhidrosis
0.125 0.875 0.000
L75.0 Bromhidrosis
0.125 0.875 0.000
L70.0 Acne vulgaris
0.124 0.876 0.000
L70.8 Other acne
0.121 0.879 0.000
L70.5 Acne excoriee des jeunes filles
0.121 0.879 0.000
L70.4 Infantile acne
0.121 0.879 0.000
L70.3 Acne tropica
0.121 0.879 0.000
L70.2 Acne varioliformis
0.121 0.879 0.000
L70.1 Acne conglobata
0.121 0.879 0.000
L70.9 Acne, unspecified
0.113 0.887 0.000
L60 Nail disorders
0.096 0.904 0.000
L71.8 Other rosacea
0.091 0.909 0.000
L71.0 Perioral dermatitis
0.091 0.909 0.000
L73.9 Follicular disorder, unspecified
0.082 0.918 0.000
L71.1 Rhinophyma
0.081 0.918 0.000
L60.9 Nail disorder, unspecified
0.071 0.928 0.000
L60.5 Yellow nail syndrome
0.069 0.931 0.000
L60.4 Beau's lines
0.069 0.931 0.000
L60.1 Onycholysis
0.069 0.931 0.000
L60.3 Nail dystrophy
0.067 0.933 0.000
L71.9 Rosacea, unspecified
0.061 0.939 0.000
L60.2 Onychogryphosis
0.061 0.939 0.000
L60.0 Ingrowing nail
0.056 0.944 0.000
L60.8 Other nail disorders
0.038 0.962 0.000
T46.1 Calcium-channel blockers
0.012 0.988 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.012 0.988 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.011 0.989 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.010 0.990 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.010 0.990 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.010 0.990 0.000
N30.3 Trigonitis
0.010 0.990 0.000
T42.4 Benzodiazepines
0.010 0.990 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.009 0.990 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.009 0.991 0.000
T43.2 Other and unspecified antidepressants
0.009 0.991 0.000
T42.0 Hydantoin derivatives
0.009 0.991 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.009 0.991 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.009 0.991 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.009 0.991 0.000
T46.7 Peripheral vasodilators
0.009 0.991 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.009 0.991 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.009 0.991 0.000
T45.0 Antiallergic and antiemetic drugs
0.008 0.992 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.008 0.992 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.008 0.992 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.008 0.992 0.000
I71.0 Dissection of aorta [any part]
0.000 0.992 0.008
Z91.5 Personal history of self-harm
0.008 0.992 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.008 0.992 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.008 0.992 0.000
T42.3 Barbiturates
0.008 0.992 0.000
T42.2 Succinimides and oxazolidinediones
0.008 0.992 0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture
0.000 0.992 0.008
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.007 0.992 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.007 0.992 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.007 0.992 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.007 0.992 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.007 0.992 0.000
J32.0 Chronic maxillary sinusitis
0.008 0.992 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.007 0.993 0.000
T45.5 Anticoagulants
0.007 0.993 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.007 0.993 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.007 0.993 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.007 0.993 0.000
T42.1 Iminostilbenes
0.007 0.993 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.007 0.993 0.000
I71 Aortic aneurysm and dissection
0.000 0.993 0.007
T45.9 Primarily systemic and haematological agent, unspecified
0.007 0.993 0.000
T45.8 Other primarily systemic and haematological agents
0.007 0.993 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.007 0.993 0.000
T45.6 Fibrinolysis-affecting drugs
0.007 0.993 0.000
T45.4 Iron and its compounds
0.007 0.993 0.000
T45.3 Enzymes, not elsewhere classified
0.007 0.993 0.000
T45.2 Vitamins, not elsewhere classified
0.007 0.993 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.007 0.993 0.000
K07.3 Anomalies of tooth position
0.000 0.993 0.007
E21.0 Primary hyperparathyroidism
0.007 0.993 0.000
T43.9 Psychotropic drug, unspecified
0.006 0.993 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.006 0.993 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.006 0.993 0.000
T31.0 Burns involving less than 10% of body surface
0.007 0.993 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.006 0.993 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.006 0.993 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.006 0.993 0.000
T36 Poisoning by systemic antibiotics
0.006 0.993 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.006 0.994 0.000
R76.8 Other specified abnormal immunological findings in serum
0.006 0.994 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.006 0.994 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.006 0.994 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.006 0.994 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.006 0.994 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.006 0.994 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.006 0.994 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.006 0.994 0.000
T44.0 Anticholinesterase agents
0.006 0.994 0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture
0.000 0.994 0.006
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.006 0.994 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.006 0.994 0.000
T47.7 Emetics
0.006 0.994 0.000
T47.6 Antidiarrhoeal drugs
0.006 0.994 0.000
T47.5 Digestants
0.006 0.994 0.000
T47.4 Other laxatives
0.006 0.994 0.000
T47.3 Saline and osmotic laxatives
0.006 0.994 0.000
T47.2 Stimulant laxatives
0.006 0.994 0.000
T47.0 Histamine H(2)-receptor antagonists
0.006 0.994 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.006 0.994 0.000
T43.6 Psychostimulants with abuse potential
0.006 0.994 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.006 0.994 0.000
S82.80 Fractures of other parts of lower leg (closed)
0.000 0.994 0.006
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.005 0.994 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.005 0.994 0.000
T37.5 Antiviral drugs
0.005 0.994 0.000
T37.4 Anthelminthics
0.005 0.994 0.000
T37.3 Other antiprotozoal drugs
0.005 0.994 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.005 0.994 0.000
T37.1 Antimycobacterial drugs
0.005 0.994 0.000
T37.0 Sulphonamides
0.005 0.994 0.000
T41.5 Therapeutic gases
0.005 0.994 0.000
T41.4 Anaesthetic, unspecified
0.005 0.994 0.000
T41.3 Local anaesthetics
0.005 0.994 0.000
T41.2 Other and unspecified general anaesthetics
0.005 0.994 0.000
T41.1 Intravenous anaesthetics
0.005 0.994 0.000
T41.0 Inhaled anaesthetics
0.005 0.994 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.005 0.994 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.005 0.994 0.000
T48.5 Anti-common-cold drugs
0.005 0.994 0.000
T48.4 Expectorants
0.005 0.994 0.000
T48.3 Antitussives
0.005 0.994 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.005 0.994 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.005 0.994 0.000
T48.0 Oxytocic drugs
0.005 0.994 0.000
T49.9 Topical agent, unspecified
0.005 0.994 0.000
T49.8 Other topical agents
0.005 0.994 0.000
T49.7 Dental drugs, topically applied
0.005 0.994 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.005 0.994 0.000
T49.5 Ophthalmological drugs and preparations
0.005 0.994 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.005 0.994 0.000
T49.3 Emollients, demulcents and protectants
0.005 0.994 0.000
T49.2 Local astringents and local detergents
0.005 0.994 0.000
T49.1 Antipruritics
0.005 0.994 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.005 0.994 0.000
T39.1 4-Aminophenol derivatives
0.006 0.994 0.000
T39.4 Antirheumatics, not elsewhere classified
0.005 0.994 0.000
T39.2 Pyrazolone derivatives
0.005 0.994 0.000
T50.8 Diagnostic agents
0.005 0.994 0.000
T50.7 Analeptics and opioid receptor antagonists
0.005 0.994 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.005 0.994 0.000
T50.5 Appetite depressants
0.005 0.994 0.000
T50.4 Drugs affecting uric acid metabolism
0.005 0.994 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.005 0.994 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.005 0.994 0.000
T50.1 Loop [high-ceiling] diuretics
0.005 0.994 0.000
T50.0 Mineralocorticoids and their antagonists
0.005 0.994 0.000
J32 Chronic sinusitis
0.006 0.994 0.000
S42.20 Fracture of upper end of humerus (closed)
0.005 0.995 0.000
I71.8 Aortic aneurysm of unspecified site, ruptured
0.000 0.995 0.005
I71.5 Thoracoabdominal aortic aneurysm, ruptured
0.000 0.995 0.005
I71.1 Thoracic aortic aneurysm, ruptured
0.000 0.995 0.005
T38.9 Other and unspecified hormone antagonists
0.005 0.995 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.005 0.995 0.000
T38.7 Androgens and anabolic congeners
0.005 0.995 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.005 0.995 0.000
T38.5 Other oestrogens and progestogens
0.005 0.995 0.000
T38.4 Oral contraceptives
0.005 0.995 0.000
T38.2 Antithyroid drugs
0.005 0.995 0.000
T38.0 Glucocorticoids and synthetic analogues
0.005 0.995 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.005 0.995 0.000
T39.0 Salicylates
0.005 0.995 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.005 0.995 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.005 0.995 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.005 0.995 0.000
I71.3 Abdominal aortic aneurysm, ruptured
0.000 0.995 0.005
M79.89 Other specified soft tissue disorders (Site unspecified)
0.000 0.995 0.005
T38.1 Thyroid hormones and substitutes
0.005 0.995 0.000
T36.9 Systemic antibiotic, unspecified
0.005 0.995 0.000
T36.8 Other systemic antibiotics
0.005 0.995 0.000
T36.7 Antifungal antibiotics, systemically used
0.005 0.995 0.000
T36.6 Rifamycins
0.005 0.995 0.000
T36.5 Aminoglycosides
0.005 0.995 0.000
T36.4 Tetracyclines
0.005 0.995 0.000
T36.3 Macrolides
0.005 0.995 0.000
T36.2 Chloramphenicol group
0.005 0.995 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.005 0.995 0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture
0.000 0.995 0.005
T43.5 Other and unspecified antipsychotics and neuroleptics
0.005 0.995 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.005 0.995 0.000
J32.9 Chronic sinusitis, unspecified
0.005 0.995 0.000
J32.1 Chronic frontal sinusitis
0.005 0.995 0.000
J32.4 Chronic pansinusitis
0.005 0.995 0.000
C44.7 Skin of lower limb, including hip
0.005 0.995 0.000
J32.2 Chronic ethmoidal sinusitis
0.004 0.996 0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.000 0.996 0.004
J32.8 Other chronic sinusitis
0.004 0.996 0.000
Z03.9 Observation for suspected disease or condition, unspecified
0.004 0.996 0.000
J32.3 Chronic sphenoidal sinusitis
0.004 0.996 0.000
T31 Burns classified according to extent of body surface involved
0.004 0.996 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.004 0.996 0.000
T40.8 Lysergide [LSD]
0.004 0.996 0.000
T40.7 Cannabis (derivatives)
0.004 0.996 0.000
T40.5 Cocaine
0.004 0.996 0.000
T40.3 Methadone
0.004 0.996 0.000
T40.1 Heroin
0.004 0.996 0.000
T40.0 Opium
0.004 0.996 0.000
T36.0 Penicillins
0.003 0.996 0.000
T40.4 Other synthetic narcotics
0.004 0.996 0.000
R76 Other abnormal immunological findings in serum
0.004 0.996 0.000
K07 Dentofacial anomalies [including malocclusion]
0.000 0.996 0.004
T31.1 Burns involving 10-19% of body surface
0.003 0.997 0.000
R19.5 Other fecal abnormalities
0.000 0.997 0.003
T40.6 Other and unspecified narcotics
0.003 0.997 0.000
K07.1 Anomalies of jaw-cranial base relationship
0.000 0.997 0.003
H81.1 Benign paroxysmal vertigo
0.003 0.997 0.000
T31.9 Burns involving 90% or more of body surface
0.003 0.997 0.000
T31.8 Burns involving 80-89% of body surface
0.003 0.997 0.000
T31.7 Burns involving 70-79% of body surface
0.003 0.997 0.000
T31.6 Burns involving 60-69% of body surface
0.003 0.997 0.000
T31.5 Burns involving 50-59% of body surface
0.003 0.997 0.000
T31.4 Burns involving 40-49% of body surface
0.003 0.997 0.000
T31.3 Burns involving 30-39% of body surface
0.003 0.997 0.000
T31.2 Burns involving 20-29% of body surface
0.003 0.997 0.000
M43.17 Spondylolisthesis (Lumbosacral region)
0.000 0.997 0.003
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.003 0.997 0.000
R76.9 Abnormal immunological finding in serum, unspecified
0.003 0.997 0.000
R76.2 False-positive serological test for syphilis
0.003 0.997 0.000
R76.1 Abnormal reaction to tuberculin test
0.003 0.997 0.000
D37.5 Rectum
0.000 0.997 0.003
K07.2 Anomalies of dental arch relationship
0.000 0.997 0.003
Chapter XII Diseases of the skin and subcutaneous tissue
0.003 0.997 0.000
H80.9 Otosclerosis, unspecified
0.003 0.997 0.000
I44.7 Left bundle-branch block, unspecified
0.000 0.997 0.003
K07.8 Other dentofacial anomalies
0.000 0.997 0.003
K07.5 Dentofacial functional abnormalities
0.000 0.997 0.003
K07.0 Major anomalies of jaw size
0.000 0.997 0.003
T40.2 Other opioids
0.003 0.997 0.000
L90.0 Lichen sclerosus et atrophicus
0.000 0.997 0.003
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.003 0.997 0.000
S42.2 Fracture of upper end of humerus
0.003 0.997 0.000
H53.4 Visual field defects
0.003 0.997 0.000
K07.6 Temporomandibular joint disorders
0.000 0.997 0.003
K07.4 Malocclusion, unspecified
0.000 0.997 0.003
I42.2 Other hypertrophic cardiomyopathy
0.003 0.997 0.000
I42.1 Obstructive hypertrophic cardiomyopathy
0.003 0.997 0.000
K07.9 Dentofacial anomaly, unspecified
0.000 0.997 0.002
R76.0 Raised antibody titer
0.002 0.997 0.000
C71.1 Frontal lobe
0.003 0.997 0.000
I42.6 Alcoholic cardiomyopathy
0.002 0.997 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.002 0.998 0.000
E21.4 Other specified disorders of parathyroid gland
0.002 0.998 0.000
E21.2 Other hyperparathyroidism
0.002 0.998 0.000
O71.4 Obstetric high vaginal laceration alone
0.002 0.998 0.000
N36.2 Urethral caruncle
0.002 0.998 0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)
0.002 0.998 0.000
Z86.0 Personal history of other neoplasms
0.002 0.998 0.000
R72 Abnormality of white blood cells, not elsewhere classified
0.002 0.998 0.000
R70-R79 Abnormal findings on examination of blood, without diagnosis
0.002 0.998 0.000
R25.2 Cramp and spasm
0.002 0.998 0.000
M94.26 Chondromalacia (Lower leg)
0.002 0.998 0.000
S42.21 Fracture of upper end of humerus (open)
0.002 0.998 0.000
Z48.8 Other specified surgical follow-up care
0.002 0.998 0.000
R71 Abnormality of red blood cells
0.002 0.998 0.000
D22.6 Melanocytic naevi of upper limb, including shoulder
0.000 0.998 0.002
L10-L14 Bullous disorders
0.002 0.998 0.000
R74 Abnormal serum enzyme levels
0.002 0.998 0.000
H81 Disorders of vestibular function
0.002 0.998 0.000
L40-L45 Papulosquamous disorders
0.002 0.998 0.000
H80 Otosclerosis
0.002 0.998 0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.002 0.998 0.000
H81.0 Meniere's disease
0.002 0.998 0.000
S82.8 Fractures of other parts of lower leg
0.000 0.998 0.002
I42 Cardiomyopathy
0.002 0.998 0.000
R78 Findings of drugs and other substances, not normally found in blood
0.002 0.998 0.000
C71 Malignant neoplasm of brain
0.002 0.998 0.000
A04.7 Enterocolitis due to Clostridium difficile
0.000 0.998 0.002
M62.81 Other specified disorders of muscle (Shoulder region)
0.002 0.998 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.998 0.002
R75 Laboratory evidence of human immunodeficiency virus [HIV]
0.002 0.998 0.000
R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
0.002 0.998 0.000
R77 Other abnormalities of plasma proteins
0.002 0.998 0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation
0.002 0.998 0.000
Z73.9 Problem related to life-management difficulty, unspecified
0.002 0.998 0.000
M62.88 Other specified disorders of muscle (Other)
0.002 0.998 0.000
N36.8 Other specified disorders of urethra
0.002 0.998 0.000
M62.8 Other specified disorders of muscle
0.002 0.998 0.000
R74.8 Abnormal levels of other serum enzymes
0.002 0.998 0.000
C71.3 Parietal lobe
0.002 0.998 0.000
L12 Pemphigoid
0.002 0.998 0.000
L10 Pemphigus
0.002 0.998 0.000
L14 Bullous disorders in diseases classified elsewhere
0.002 0.998 0.000
R73 Elevated blood glucose level
0.002 0.998 0.000
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity
0.002 0.998 0.000
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation
0.002 0.998 0.000
R74.9 Abnormal level of unspecified serum enzyme
0.002 0.998 0.000
M62.89 Other specified disorders of muscle (Site unspecified)
0.002 0.998 0.000
M62.85 Other specified disorders of muscle (Pelvic region and thigh)
0.002 0.998 0.000
H81.4 Vertigo of central origin
0.002 0.998 0.000
R78.0 Finding of alcohol in blood
0.002 0.998 0.000
C71.2 Temporal lobe
0.002 0.998 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.000 0.998 0.002
I42.9 Cardiomyopathy, unspecified
0.002 0.998 0.000
M94.2 Chondromalacia
0.002 0.998 0.000
C71.4 Occipital lobe
0.002 0.998 0.000
E21.3 Hyperparathyroidism, unspecified
0.002 0.998 0.000
H80.8 Other otosclerosis
0.002 0.998 0.000
H80.2 Cochlear otosclerosis
0.002 0.998 0.000
H80.1 Otosclerosis involving oval window, obliterative
0.002 0.998 0.000
H80.0 Otosclerosis involving oval window, nonobliterative
0.002 0.998 0.000
L44 Other papulosquamous disorders
0.002 0.998 0.000
L41 Parapsoriasis
0.002 0.998 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.002 0.998 0.000
M62.86 Other specified disorders of muscle (Lower leg)
0.002 0.998 0.000
H81.8 Other disorders of vestibular function
0.002 0.998 0.000
R73.0 Abnormal glucose tolerance test
0.002 0.998 0.000
L11 Other acantholytic disorders
0.002 0.998 0.000
L58 Radiodermatitis
0.002 0.998 0.000
L55 Sunburn
0.002 0.998 0.000
S82.86 Maisonneuve's fracture
0.000 0.998 0.002
I42.7 Cardiomyopathy due to drugs and other external agents
0.002 0.998 0.000
I42.5 Other restrictive cardiomyopathy
0.002 0.998 0.000
I42.4 Endocardial fibroelastosis
0.002 0.998 0.000
I42.3 Endomyocardial (eosinophilic) disease
0.002 0.998 0.000
L40 Psoriasis
0.002 0.998 0.000
L56 Other acute skin changes due to ultraviolet radiation
0.002 0.998 0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.002 0.998 0.000
C71.0 Cerebrum, except lobes and ventricles
0.002 0.998 0.000
R78.9 Finding of unspecified substance, not normally found in blood
0.002 0.998 0.000
R78.8 Finding of other specified substances, not normally found in blood
0.002 0.998 0.000
R78.7 Finding of abnormal level of heavy metals in blood
0.002 0.998 0.000
R78.6 Finding of steroid agent in blood
0.002 0.998 0.000
R78.5 Finding of psychotropic drug in blood
0.002 0.998 0.000
R78.4 Finding of other drugs of addictive potential in blood
0.002 0.998 0.000
R78.3 Finding of hallucinogen in blood
0.002 0.998 0.000
R78.2 Finding of cocaine in blood
0.002 0.998 0.000
R78.1 Finding of opiate drug in blood
0.002 0.998 0.000
L13 Other bullous disorders
0.002 0.998 0.000
C71.7 Brain stem
0.002 0.998 0.000
C71.6 Cerebellum
0.002 0.998 0.000
C71.5 Cerebral ventricle
0.002 0.998 0.000
C71.9 Brain, unspecified
0.002 0.998 0.000
C71.8 Overlapping lesion of brain
0.002 0.998 0.000
R06.5 Mouth breathing
0.000 0.998 0.002
L43 Lichen planus
0.002 0.998 0.000
O82.1 Delivery by emergency Caesarean section
0.002 0.998 0.000
R77.2 Abnormality of alphafetoprotein
0.002 0.998 0.000
R77.1 Abnormality of globulin
0.002 0.998 0.000
R77.0 Abnormality of albumin
0.002 0.998 0.000
H81.9 Disorder of vestibular function, unspecified
0.002 0.998 0.000
L40.4 Guttate psoriasis
0.002 0.998 0.000
R77.8 Other specified abnormalities of plasma proteins
0.002 0.998 0.000
C17.0 Duodenum
0.002 0.998 0.000
K14.8 Other diseases of tongue
0.002 0.998 0.000
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified
0.001 0.998 0.000
L59.0 Erythema ab igne [dermatitis ab igne]
0.001 0.998 0.000
R77.9 Abnormality of plasma protein, unspecified
0.002 0.998 0.000
Z99.8 Dependence on other enabling machines and devices
0.000 0.998 0.002
S62.20 Fracture of first metacarpal bone (closed)
0.000 0.998 0.002
H50.1 Divergent concomitant strabismus
0.002 0.998 0.000
H81.3 Other peripheral vertigo
0.001 0.998 0.000
M62.87 Other specified disorders of muscle (Ankle and foot)
0.002 0.998 0.000
M62.84 Other specified disorders of muscle (Hand)
0.002 0.998 0.000
M62.83 Other specified disorders of muscle (Forearm)
0.002 0.998 0.000
E07.9 Disorder of thyroid, unspecified
0.002 0.998 0.000
L40.3 Pustulosis palmaris et plantaris
0.002 0.998 0.000
L43.8 Other lichen planus
0.002 0.998 0.000
L56.9 Acute skin change due to ultraviolet radiation, unspecified
0.001 0.998 0.000
H74.4 Polyp of middle ear
0.000 0.998 0.002
L12.9 Pemphigoid, unspecified
0.001 0.998 0.000
L12.8 Other pemphigoid
0.001 0.998 0.000
L12.3 Acquired epidermolysis bullosa
0.001 0.998 0.000
L12.2 Chronic bullous disease of childhood
0.001 0.998 0.000
L12.1 Cicatricial pemphigoid
0.001 0.998 0.000
M62.82 Other specified disorders of muscle (Upper arm)
0.001 0.998 0.000
K63.8 Other specified diseases of intestine
0.002 0.998 0.000
L10.9 Pemphigus, unspecified
0.001 0.998 0.000
L10.8 Other pemphigus
0.001 0.998 0.000
L10.5 Drug-induced pemphigus
0.001 0.998 0.000
L10.4 Pemphigus erythematosus
0.001 0.998 0.000
L10.3 Brazilian pemphigus [fogo selvagem]
0.001 0.998 0.000
L10.2 Pemphigus foliaceus
0.001 0.998 0.000
L10.1 Pemphigus vegetans
0.001 0.998 0.000
L10.0 Pemphigus vulgaris
0.001 0.998 0.000
L12.0 Bullous pemphigoid
0.001 0.998 0.000
R70.1 Abnormal plasma viscosity
0.001 0.998 0.000
N50.8 Other specified disorders of male genital organs
0.002 0.998 0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)
0.002 0.998 0.000
M94.29 Chondromalacia (Site unspecified)
0.001 0.998 0.000
M94.28 Chondromalacia (Other)
0.001 0.998 0.000
M94.27 Chondromalacia (Ankle and foot)
0.001 0.998 0.000
M94.25 Chondromalacia (Pelvic region and thigh)
0.001 0.998 0.000
M94.24 Chondromalacia (Hand)
0.001 0.998 0.000
M94.23 Chondromalacia (Forearm)
0.001 0.998 0.000
M94.22 Chondromalacia (Upper arm)
0.001 0.998 0.000
M94.21 Chondromalacia (Shoulder region)
0.001 0.998 0.000
M94.20 Chondromalacia (Multiple sites)
0.001 0.998 0.000
L41.9 Parapsoriasis, unspecified
0.001 0.998 0.000
L41.8 Other parapsoriasis
0.001 0.998 0.000
L41.5 Retiform parapsoriasis
0.001 0.998 0.000
L41.4 Large plaque parapsoriasis
0.001 0.998 0.000
L41.3 Small plaque parapsoriasis
0.001 0.998 0.000
L41.2 Lymphomatoid papulosis
0.001 0.998 0.000
L41.1 Pityriasis lichenoides chronica
0.001 0.998 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.001 0.998 0.000
L44.9 Papulosquamous disorder, unspecified
0.001 0.998 0.000
L44.8 Other specified papulosquamous disorders
0.001 0.998 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.001 0.998 0.000
L44.3 Lichen ruber moniliformis
0.001 0.998 0.000
L44.2 Lichen striatus
0.001 0.998 0.000
L44.1 Lichen nitidus
0.001 0.998 0.000
L44.0 Pityriasis rubra pilaris
0.001 0.998 0.000
Q54.9 Hypospadias, unspecified
0.002 0.998 0.000
S06.6 Traumatic subarachnoid haemorrhage
0.002 0.998 0.000
M25.06 Haemarthrosis (Lower leg)
0.000 0.998 0.002
M94.96 Disorder of cartilage, unspecified (Lower leg)
0.001 0.998 0.000
H81.2 Vestibular neuronitis
0.001 0.998 0.000
L11.9 Acantholytic disorder, unspecified
0.001 0.998 0.000
L11.8 Other specified acantholytic disorders
0.001 0.998 0.000
L11.1 Transient acantholytic dermatosis [Grover]
0.001 0.998 0.000
L55.9 Sunburn, unspecified
0.001 0.998 0.000
L55.8 Other sunburn
0.001 0.998 0.000
L55.2 Sunburn of third degree
0.001 0.998 0.000
L55.1 Sunburn of second degree
0.001 0.998 0.000
L55.0 Sunburn of first degree
0.001 0.998 0.000
L56.4 Polymorphous light eruption
0.001 0.998 0.000
L56.3 Solar urticaria
0.001 0.998 0.000
L56.2 Photocontact dermatitis [berloque dermatitis]
0.001 0.998 0.000
L56.1 Drug photoallergic response
0.001 0.998 0.000
L56.0 Drug phototoxic response
0.001 0.998 0.000
L58.9 Radiodermatitis, unspecified
0.001 0.998 0.000
L58.1 Chronic radiodermatitis
0.001 0.998 0.000
L58.0 Acute radiodermatitis
0.001 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.